These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16702043)

  • 21. No case of COX-1-related aspirin resistance found in 289 patients with symptoms of stable CHD remitted for coronary angiography.
    Meen O; Brosstad F; Khiabani H; Gjertsen E; Lauritsen ME; Pedersen TM; Bjørnsen S; Schjelderup NM; Ameln W; Ng EC; Wettergreen M; Siddique SP; Erikssen G
    Scand J Clin Lab Invest; 2008; 68(3):185-91. PubMed ID: 17934975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance.
    Frelinger AL; Furman MI; Linden MD; Li Y; Fox ML; Barnard MR; Michelson AD
    Circulation; 2006 Jun; 113(25):2888-96. PubMed ID: 16785341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal suppression of thromboxane A(2) formation by aspirin during percutaneous transluminal coronary angioplasty: no additional effect of a selective cyclooxygenase-2 inhibitor.
    Kearney D; Byrne A; Crean P; Cox D; Fitzgerald DJ
    J Am Coll Cardiol; 2004 Feb; 43(4):526-31. PubMed ID: 14975458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease.
    Lordkipanidzé M; Pharand C; Schampaert E; Turgeon J; Palisaitis DA; Diodati JG
    Eur Heart J; 2007 Jul; 28(14):1702-8. PubMed ID: 17569678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between endothelial dysfunction, oxidant stress and aspirin resistance in patients with stable coronary heart disease.
    Cheng G; Shan J; Xu G; Liu P; Zhou Y; Zhu Y; Lu X
    J Clin Pharm Ther; 2007 Jun; 32(3):287-92. PubMed ID: 17489881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogeneity in platelet cyclooxygenase inhibition by aspirin in coronary artery disease.
    Lordkipanidzé M; Pharand C; Schampaert E; Palisaitis DA; Diodati JG
    Int J Cardiol; 2011 Jul; 150(1):39-44. PubMed ID: 20207433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alternative splicing of cyclooxygenase-1 gene: altered expression in leucocytes from patients with bronchial asthma and association with aspirin-induced 15-HETE release.
    Kowalski ML; Borowiec M; Kurowski M; Pawliczak R
    Allergy; 2007 Jun; 62(6):628-34. PubMed ID: 17508966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphisms of COX-1 and GPVI associate with the antiplatelet effect of aspirin in coronary artery disease patients.
    Lepäntalo A; Mikkelsson J; Reséndiz JC; Viiri L; Backman JT; Kankuri E; Karhunen PJ; Lassila R
    Thromb Haemost; 2006 Feb; 95(2):253-9. PubMed ID: 16493486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet response to low-dose enteric-coated aspirin in patients with stable cardiovascular disease.
    Maree AO; Curtin RJ; Dooley M; Conroy RM; Crean P; Cox D; Fitzgerald DJ
    J Am Coll Cardiol; 2005 Oct; 46(7):1258-63. PubMed ID: 16198840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic determinants of response to aspirin: appraisal of 4 candidate genes.
    Lordkipanidzé M; Diodati JG; Palisaitis DA; Schampaert E; Turgeon J; Pharand C
    Thromb Res; 2011 Jul; 128(1):47-53. PubMed ID: 21429568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclooxygenase inhibition in patients with coronary artery disease.
    Frishman WH
    J Am Coll Cardiol; 2004 Feb; 43(4):532-3. PubMed ID: 14975459
    [No Abstract]   [Full Text] [Related]  

  • 32. New direct and indirect methods for the detection of cyclooxygenase 1 acetylation by aspirin; the lack of aspirin resistance among healthy individuals.
    Kovács EG; Katona E; Bereczky Z; Homoródi N; Balogh L; Tóth E; Péterfy H; Kiss RG; Edes I; Muszbek L
    Thromb Res; 2013 Apr; 131(4):320-4. PubMed ID: 23422285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Over-expression of cyclooxygenase-2 in increased reticulated platelets leads to aspirin resistance after elective off-pump coronary artery bypass surgery.
    Gong X; Wang X; Xu Z; Zhu T; Zhang Q; Zhang J; Wang X; Li C
    Thromb Res; 2017 Dec; 160():114-118. PubMed ID: 29149707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Partial inhibition of platelet thromboxane A2 synthesis by aspirin is associated with myonecrosis in patients with ST-segment elevation myocardial infarction.
    Valles J; Santos MT; Fuset MP; Moscardo A; Ruano M; Perez F; Piñon M; Breña S; Aznar J
    Am J Cardiol; 2007 Jan; 99(1):19-25. PubMed ID: 17196455
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The aspirin resistance controversy: clinical entity or platelet heterogeneity?
    Freedman JE
    Circulation; 2006 Jun; 113(25):2865-7. PubMed ID: 16801473
    [No Abstract]   [Full Text] [Related]  

  • 36. Mechanisms of aspirin resistance.
    Floyd CN; Ferro A
    Pharmacol Ther; 2014 Jan; 141(1):69-78. PubMed ID: 23993980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optical platelet aggregation versus thromboxane metabolites in healthy individuals and patients with stable coronary artery disease after low-dose aspirin administration.
    Hedegaard SS; Hvas AM; Grove EL; Refsgaard J; Rocca B; Daví G; Kristensen SD
    Thromb Res; 2009 May; 124(1):96-100. PubMed ID: 19215971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease.
    Renda G; Tacconelli S; Capone ML; Sacchetta D; Santarelli F; Sciulli MG; Zimarino M; Grana M; D'Amelio E; Zurro M; Price TS; Patrono C; De Caterina R; Patrignani P
    Clin Pharmacol Ther; 2006 Sep; 80(3):264-74. PubMed ID: 16952493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aspirin resistance: is this term meaningful?
    Violi F; Pignatelli P
    Curr Opin Hematol; 2006 Sep; 13(5):331-6. PubMed ID: 16888437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cyclooxygenase-1 C50T polymorphism is not associated with aspirin responsiveness status in stable coronary artery disease in Tunisian patients.
    Chakroun T; Addad F; Yacoub S; Abderrezak F; Gerotziafas GT; Abdelkafi S; Hassine M; Gamra H; Hatmi M; Elalamy I
    Genet Test Mol Biomarkers; 2011; 15(7-8):513-6. PubMed ID: 21434767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.